#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurotrophic keratopathy Pemphigus Obliterative bronchiolitis Obesity Glycogen storage disease type V Gastrointestinal disorder Malignant peritoneal neoplasm Small intestine leiomyosarcoma Langerhans cell sarcoma Progressive familial intrahepatic cholestasis Cutaneous T-cell lymphoma stage I Hereditary neuropathic amyloidosis Angiosarcoma recurrent Hypomagnesaemia Cerebral amyloid angiopathy More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma Rhabdomyosarcoma recurrent – Treatment Angiosarcoma – Basic Information Phenylketonuria – Life with Disease Angelman’s syndrome – Trials in Disease Idiopathic pulmonary fibrosis – Basic Information Idiopathic pulmonary fibrosis – Diagnostics Activated PI3 kinase delta syndrome – Trials in Disease Mast cell activation syndrome – Trials in Disease Toxic epidermal necrolysis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tenofovir Alafenamide Mirvetuximab Soravtansine Efinopegdutide Nemvaleukin Alfa Prasinezumab Ulonivirine Carmustine Gskvx000000017033 Dextromethadone Hydrochloride Salbutamol Eptacog Alfa (Activated) Tecaginlimab Niflumic Acid Tafasitamab Io103 Acetate Meclofenamate Sodium Zoledronic Acid Monohydrate Rifamycin Sodium Topiramate Dexamethasone Sodium Phosphate More therapies…

    Learn about Your Condition

    Limb reduction defect Epithelioid sarcoma Renal impairment Liposarcoma recurrent Immune thrombocytopenia Hand fracture Muscle hypertrophy Epileptic encephalopathy Eyelid ptosis Metabolic syndrome Kaposi's sarcoma Altered state of consciousness Muscle spasticity Paget's disease of the vulva Diabetic retinal oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Gemeinschaftspraxis Dres. Holger Kittner und Kerstin…

Gemeinschaftspraxis Dres. Holger Kittner und Kerstin Hartig

Kurze Str. 7, Naunhof, 04683, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Lavender Oil
    Austria Germany

  • Study on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Germany

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Austria Belgium Bulgaria Czechia Denmark France +11

  • A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

  • Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

    Not recruiting

    2 1
    Investigated Drugs:
    • Cannabis Sativa Flower
    Czechia Germany Poland

  • Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!